| | 
Part, Chapter, Paragraph
1 -, 1 | 2004 and to 27 countries in 2007, but also previously-identified
2 I, 2. 2 | report by Rudiger Leidner (2007) entitled “The European
3 I, 2. 4 | capita in EUGLOREH Countries, 2007.~ ~GDP is defined as the
4 I, 2. 5 | During the period 2006-2007 6.5 million new jobs have
5 I, 2. 7 | almost 5 billion (UNFPA, 2007). In most countries, the
6 I, 2. 7 | healthcare services (Marrone, 2007; Arcury et al, 2005).~ ~
7 I, 2. 9 | and the spring drought of 2007. Since extreme events are
8 I, 2. 10. 2 | NIOSH, 2006; Schulte et al, 2007; Nel et al, 2006; Medina
9 I, 2. 10. 2 | al, 2006; Medina et al, 2007).~ ~The nanoparticles categories
10 I, 2. 10. 2 | al, 2006); (Medina et al, 2007).~ ~- Carbon nanoparticles:
11 I, 2. 10. 2 | reported so far (September 2007) 4. In the US, the Woodrow
12 I, 2. 10. 4(8) | Practisise. Council of Europe - 2007~
13 I, 2. 10. 4(9) | of Healthh – 16 February 2007~
14 I, 2. 10. 4(12)| of Health – 16 Febrauary 2007~
15 I, 2. 10. 4(14)| European Commission, May 2007.~
16 I, 2. 10. 4(19)| of health – 16 February 2007~
17 I, 2. 10. 4(21)| P- SP-PH- SAFE), 19 March 2007~
18 I, 2. 10. 4(22)| of Health – 16 February 2007~
19 I, 2. 11 | ILO, Geneva~Marrone S (2007): Understanding barriers
20 I, 2. 11 | Int J Circumpolar Health. 2007 Jun;66(3):188-98.~Medina
21 I, 2. 11 | 188-98.~Medina c. et al. (2007): Nanoparticles: pharmacological
22 I, 2. 11 | Schulte P.A. et al. (2007): Ethical and Scientific
23 I, 2. 11 | Population Fund (UNFPA) (2007): State of the world population
24 I, 2. 11 | of the world population 2007. Available at: htt ~ ~
25 II, 4. 1 | et al, 1997; Kung et al, 2007)4 and the Japanese data
26 II, 4. 1 | States (Robine and Jagger, 2007). Several services of the
27 II, 4. 3 | H., D. Hoyert, et al. (2007): Deaths: Preliminary Data
28 II, 4. 3 | Robine, J.-M. and C. Jagger (2007): Healthy life expectancy
29 II, 4. 3 | Robine, J.-M. and C. Jagger (2007): Strategic Plan of the
30 II, 4. 3 | on Health Expectancies, 2007-2010. Montpellier, Inserm~ ~
31 II, 5. 1. 1 | of stomach cancer (WCRF, 2007).~ ~Colorectal cancer: the
32 II, 5. 1. 1 | against this cancer (WCRF, 2007). Cancer control priority
33 II, 5. 1. 1 | diagnosed in premenopause (WCRF, 2007).~ ~Cervical cancer: the
34 II, 5. 2. 2 | reported: EUROSTAT (htt u, 2007) for mortality data; WHO-HFA
35 II, 5. 2. 2 | WHO-HFA database (htt b, 2007), specific projects such
36 II, 5. 2. 2 | disease (WHO MONICA) (ht /, 2007) and population-based registers
37 II, 5. 2. 2 | Surveillance Set - (h p, 2007) IHD data available from
38 II, 5. 2. 2 | Muller-Nordhorn et al, 2007; Muller-Nordhorn et al,
39 II, 5. 2. 2 | mortality rates (htt u, 2007).~IHD mortality was defined
40 II, 5. 2. 2 | diagnoses from WHO-HFA (htt b, 2007) were used to calculate
41 II, 5. 2. 2 | Surveillance Set - (h p, 2007) EUROSTAT data were analyzed
42 II, 5. 2. 2 | mortality rates (htt u, 2007). Stroke mortality was defined
43 II, 5. 2. 2 | diagnoses from WHO-HFA (htt b, 2007) and EUROSTAT (htt u, 2007)
44 II, 5. 2. 2 | 2007) and EUROSTAT (htt u, 2007) were used for stroke; these
45 II, 5. 2. 2 | WHO MONICA Project (htt /, 2007) are reported for the age
46 II, 5. 2. 2 | WHO-MONICA Project (htt /, 2007) was based on clinical findings (
47 II, 5. 2. 2 | WHO HFA database (htt b, 2007). The risk factors identified
48 II, 5. 2. 3 | last year available (htt b, 2007). Unfortunately these data
49 II, 5. 2. 3 | last year available (htt b, 2007). Unfortunately, these data
50 II, 5. 2. 4 | surveys. Table 5.2.7 (htt b, 2007) provides the most recent
51 II, 5. 2. 4 | Congress held in Vienna (2007). The EUROASPIRE surveys
52 II, 5. 2. 5 | al, 2006; Hozawa et al, 2007; Daviglus et al, 2007).
53 II, 5. 2. 5 | al, 2007; Daviglus et al, 2007). Low risk individuals live
54 II, 5. 2. 5 | al, 2004, Graham I et al, 2007)~Within this context, blood
55 II, 5. 2. 5 | officially launched on 12 June 2007 before the European Parliament
56 II, 5. 2. 6 | epidemiological methods (htt p, 2007)~IHD is a complex disease
57 II, 5. 2. 6 | Food and Nutrition Policy 2007-2012 (WHO, 2007) establishes
58 II, 5. 2. 6 | Nutrition Policy 2007-2012 (WHO, 2007) establishes health, nutrition,
59 II, 5. 2. 6 | studies (Lewington et al, 2007). From a mechanistic point
60 II, 5. 2. 6 | established CVD) (Graham I et al, 2007).~ ~Focus Box References (
61 II, 5. 2. 6 | Qizilbash N, Peto R, Collins R (2007): Prospective Studies Collaboration:
62 II, 5. 2. 7 | Sharrett AR, Chambless LE (2007): Absolute and Attributable
63 II, 5. 2. 7 | Regional Office for Europe (2007): The Second WHO European
64 II, 5. 2. 7 | Food and Nutrition Policy 2007-2012 [http://www.euro.who.
65 II, 5. 2. 7 | pdf] (accessed on 17 march 2007).~Yusuf S, Hawken S, Ounpuu
66 II, 5. 3. 2 | Zanetti and Primic-Zakelj, 2007)~ ~Unlike other communicable
67 II, 5. 3. 2 | al, 2003; Berrino et al, 2007)~ ~· Contributing to the
68 II, 5. 3. 2 | is currently absent.~ ~In 2007 the EUROCHIP Project gave
69 II, 5. 3. 3 | year 2006 (Ferlay et al, 2007).~- Cancer incidence estimates
70 II, 5. 3. 3 | estimates in 2006 (Ferlay et al, 2007). The WHO Database provides
71 II, 5. 3. 3 | al, 2003; Berrino et al, 2007; Verdecchia et al, 2007).
72 II, 5. 3. 3 | 2007; Verdecchia et al, 2007). In the case of Czech Republic,
73 II, 5. 3. 4 | of stomach cancer (WCRF, 2007).~ ~Colorectal cancer: the
74 II, 5. 3. 4 | against this cancer (WCRF, 2007). Cancer control priority
75 II, 5. 3. 4 | diagnosed in premenopause (WCRF, 2007).~ ~Cervical cancer: the
76 II, 5. 3. 5 | around Europe (Ferlay et al, 2007). Maximum incidence rates (
77 II, 5. 3. 5 | stomach cancer (Ferlay et al, 2007). In 2006 maximum levels
78 II, 5. 3. 5 | in Europe (Ferlay et al, 2007). Figures 5.3.9 show that
79 II, 5. 3. 5 | estimated deaths (Ferlay et al, 2007). Worldwide, it is by far
80 II, 5. 3. 5 | entire Europe (Ferlay et al, 2007). The high incidence rates
81 II, 5. 3. 5 | Figure 5.3.19 shows that in 2007 mortality rates varied by
82 II, 5. 3. 5 | in Europe (Ferlay et al, 2007). Comparison of prostate
83 II, 5. 3. 6 | 1995-1999~Berrino et al (2007) analysed data from 83 cancer
84 II, 5. 3. 6 | 2000-2002~Verdecchia et al (2007) analysed survival data
85 II, 5. 3. 7 | detectable (Hakama and De Konig, 2007).~ ~Screening has been shown
86 II, 5. 3. 7 | cancer drugs” (Jonsson et al, 2007) highlights the inequities
87 II, 5. 3. 7 | community (Haward and Borras, 2007):~ ~ All populations need
88 II, 5. 3. 7 | other European States in 2007~ ~ ~BELGIUM~No~BULGARIA~
89 II, 5. 3. 7 | Source: Haward R, Borras MJ (2007)~ ~ ~Important unexplained
90 II, 5. 3. 7 | minimal additional cost.~ ~The 2007 Portuguese Presidency of
91 II, 5. 3. 7 | European Parliament (October 2007) calls on the Council and
92 II, 5. 3. 8 | outlined (Micheli et al, 2007). Moreover, the successful
93 II, 5. 3. 9 | EUROCARE Working group (2007): Survival for eight major
94 II, 5. 3. 9 | M, Colombet M, Boyle P (2007): Estimates of the cancer
95 II, 5. 3. 9 | Hakama M, De Koning H (2007): Portuguese Presidency
96 II, 5. 3. 9 | the EU (July – December 2007) Health Strategies in Europe,
97 II, 5. 3. 9 | in Europe, 12 – 13 July 2007, Strategies on Specific
98 II, 5. 3. 9 | Haward R, Borras MJ (2007): Portuguese Presidency
99 II, 5. 3. 9 | the EU (July – December 2007) Health Strategies in Europe,
100 II, 5. 3. 9 | in Europe, 12 – 13 July 2007, Strategies on Specific
101 II, 5. 3. 9 | Jonsson B, Wilking N (2007): Summary. Ann Onc 18 (Suppl
102 II, 5. 3. 9 | Verdecchia A, Pierotti MA (2007): Strategies for cancer
103 II, 5. 3. 9 | 8 (9): 784-796.~ ~WCRF (2007): Food, Nutrition, Physical activity,
104 II, 5. 4. 1 | ethnic differences. (Smith, 2007; Dyhr, 2007; Diaz, 2007).
105 II, 5. 4. 1 | differences. (Smith, 2007; Dyhr, 2007; Diaz, 2007). Specific individual
106 II, 5. 4. 1 | 2007; Dyhr, 2007; Diaz, 2007). Specific individual characteristics
107 II, 5. 4. 2 | Countries for the years 2007 and forecasts are given
108 II, 5. 4. 3 | studied (TRIGR study group. 2007). A steady increase of the
109 II, 5. 4. 3 | According to the IDF, in 2007 a total of over 300,000
110 II, 5. 4. 6 | According to Waugh et al (2007), the scope for screening
111 II, 5. 4. 6 | recent paper (Jessani et al. 2007) investigated patients with
112 II, 5. 4. 6 | observed every year starting in 2007.~ ~
113 II, 5. 4. 8 | of Public Health.~Dia A (2007): How does ethnicity affect
114 II, 5. 4. 8 | Med. Eprint Aug 24~Dyhr J (2007): Immigrants and type 2
115 II, 5. 4. 8 | 10 October 2008)~Jes . (2007); Should oral glucose tolerance
116 II, 5. 4. 8 | Inform. 2002;90:282-7.~Smi P (2007): Economics of Health and
117 II, 5. 4. 8 | 104(33):13225-31~TRIG p (2007): Study design of the Trial
118 II, 5. 4. 8 | Diabetes 8(3):117-37~Waug A (2007): Screening for type 2 diabetes:
119 II, 5. 4. 8 | modelling Health Technol Assess. 2007 May;11(17):iii-iv, ix-xi,
120 II, 5. 5. 1 | two to threefold (Fryers, 2007, Blakely et al, 2003) although
121 II, 5. 5. 1 | indirect costs (Sobocki et al, 2007).~ ~Undertreatment and underrecognition
122 II, 5. 5. 1 | depression are common (Lecrubier, 2007). In Europe, only one third
123 II, 5. 5. 1 | mood disorders (Kessler, 2007). Anxiety disorders are
124 II, 5. 5. 1 | States (Kessler et al., 2007). The onset of anxiety symptoms
125 II, 5. 5. 1 | adulthood (Kessler et al., 2007). Anxiety disorders are
126 II, 5. 5. 1 | anxiety disorders (Fryers, 2007).~ ~Anxiety disorders cause
127 II, 5. 5. 1 | recent year available as of 2007). Lithuania, Hungary and
128 II, 5. 5. 1 | of the country (Kennelly, 2007).~ ~Non-fatal self-harm.
129 II, 5. 5. 1 | Alonso J, Lépine JP (2007). Overview of key data from
130 II, 5. 5. 1 | health_en.htm~ ~Fryers T (2007). Childhood determinants
131 II, 5. 5. 1 | Longevity Center.~ ~Kennelly B (2007). The economic cost of suicide
132 II, 5. 5. 1 | Crisis 28(2):89-94.~ ~K B (2007): Lifetime prevalence and
133 II, 5. 5. 1 | MHEDEA 2000 Investigators (2007). Differences in lifetime
134 II, 5. 5. 1 | Services 58: 213-220.~ ~L . (2007). Widespread under-recognition
135 II, 5. 5. 1 | 2):87-98.~ ~S F et al. (2007). The economic burden of
136 II, 5. 5. 2 | available) (Alzheimer Europe, 2007).~ ~
137 II, 5. 5. 2 | Foundation, 2008; EPHA, 2007)~ ~In the framework of Alzheimer
138 II, 5. 5. 2 | 2008 (Alzheimer Europe, 2007).~ ~
139 II, 5. 5. 2 | dependent relatives.~ ~In 2007, Alzheimer Europe received
140 II, 5. 5. 2 | EuroCoDe” (Alzheimer Europe, 2007). This led to the creation
141 II, 5. 5. 2 | Bundesministerium der Justiz, 2007). Switzerland, the Netherlands
142 II, 5. 5. 2 | developments~ ~September 2007 saw the launch of the Paris
143 II, 5. 5. 2 | Europe~ ~Alzheimer Europe (2007): EuroCoDe, WP4 survey on
144 II, 5. 5. 2 | Bundesministerium der Justiz (2007): better protection for
145 II, 5. 5. 2 | accessed on 13 December 2007)~ ~Cooper B (2002): Thinking
146 II, 5. 5. 2 | Public Health Alliance (2007): summary of a report by
147 II, 5. 5. 2 | accessed on 30 November 2007)~ ~European Parliament (
148 II, 5. 5. 3 | attitudes (Berkman et al, 2007). An anorectic or bulimic
149 II, 5. 5. 3 | articles (Berkman et al, 2007; Hoek and van Hoeken, 2003).~ ~
150 II, 5. 5. 3 | sufficient yet (Berkman et al, 2007). Alexander and Rigby (in
151 II, 5. 5. 3 | published yet (De Henauw et al, 2007). ~ ~ ~
152 II, 5. 5. 3 | WHO, 2004).~Berkman et al (2007) reviewed various surveys,
153 II, 5. 5. 3 | resources (Berkman et al, 2007). Social pressure to be
154 II, 5. 5. 3 | Lohr, K. N.; Bulik, C. M. (2007): Outcomes of Eating Disorders:
155 II, 5. 5. 3 | the HELENA Study Group (2007): Nutritional status and
156 II, 5. 5. 3 | online, accessed on 12 March 2007).~The Cleveland Clinic Foundation (
157 II, 5. 5. 3 | online, accessed on 12 March 2007).~World Health Organization (
158 II, 5. 5. 3 | et al, 1997; Saha et al, 2007).~Aetiology – Symptoms –
159 II, 5. 5. 3 | and suicide (Saha et al, 2007). Databases on suicides
160 II, 5. 5. 3 | stated in literature (Saha, 2007).~People with schizophrenia
161 II, 5. 5. 3 | increased over time (Saha et al, 2007). A recent epidemiological
162 II, 5. 5. 3 | middle age (Fors et al, 2007).~Thus, mortality increasing
163 II, 5. 5. 3 | the mortality rate (Saha, 2007).~The mortality data attributed
164 II, 5. 5. 3 | Statistical Committee (NOMESCO, 2007) indicate that there is
165 II, 5. 5. 3 | health conditions (WHO, 2007). In terms of years lived
166 II, 5. 5. 3 | research and practice (Priebe, 2007). The importance of social
167 II, 5. 5. 3 | population (Leucht et al, 2007).~Available statistics do
168 II, 5. 5. 3 | pathomechanism (Prince et al, 2007). In addition, people affected
169 II, 5. 5. 3 | Pitschel-Walz and Bäuml, 2007) demonstrated beneficial
170 II, 5. 5. 3 | al, 2005; Klosterkötter, 2007).~The gap between need and
171 II, 5. 5. 3 | sociotherapy (Pitschel-Walz, 2007; Vauth, 2006,; Glynn, 2003;
172 II, 5. 5. 3 | drug class (Knapp et al, 2007). According to NOMESCO figures,
173 II, 5. 5. 3 | atypicals (Knapp et al, 2007) (Figure 5.5.3.3.5).~Figure
174 II, 5. 5. 3 | consequences (Byerly et al, 2007). A substantial proportion
175 II, 5. 5. 3 | in Italy (Buizza et al, 2007) evaluated four dimensions
176 II, 5. 5. 3 | contacts (Lysaker et al, 2007) – factors associated with
177 II, 5. 5. 3 | provision of care (Sartorius, 2007). Stigma marks those who
178 II, 5. 5. 3 | mentally ill (Fang and Rizzo, 2007).~Schizophrenia especially
179 II, 5. 5. 3 | diagnosis (Baumann et al, 2007).~As stated in the EU Green
180 II, 5. 5. 3 | years (Lindström et al, 2007)~Table 5.5.3.2.6. Expenditures
181 II, 5. 5. 3 | EU strategy (Knapp et al, 2007).~Database~Since strategies
182 II, 5. 5. 3 | symptoms (Klosterkötter, 2007). Respective programmes –
183 II, 5. 5. 3 | W, Möller HJ, Gaebel W (2007): Changes in the public'
184 II, 5. 5. 3 | G, Ghilardi A, Pioli R (2007): The stigma of schizophrenia
185 II, 5. 5. 3 | Nakonezny PA, Lescouflair E (2007): Antipsychotic medication
186 II, 5. 5. 3 | pdf; last accessed Dec 13, 2007.~European Commission (2006):
187 II, 5. 5. 3 | htm; last accessed Dec 13, 2007.~European Commission (2006a):
188 II, 5. 5. 3 | eds.).~Fang H, Rizzo JA (2007): Do psychiatrists have
189 II, 5. 5. 3 | Bingefors K, Widerlöv B (2007): Mortality among persons
190 II, 5. 5. 3 | W, Decker P, Möller HJ. (2007): Evaluation of the German
191 II, 5. 5. 3 | interventions. Schizophr Res. 2007 Oct 23 [Epub ahead of print].~
192 II, 5. 5. 3 | 1085-1097.~Klosterkötter J (2007): Prevention in Psychiatry: “
193 II, 5. 5. 3 | Mossialos E, Thornicroft G (2007): Mental Health Policy and
194 II, 5. 5. 3 | Henderson J, Maj M, Sartorius N (2007): Physical illness and schizophrenia:
195 II, 5. 5. 3 | Neovius M, Levander S (2007): Costs of schizophrenia
196 II, 5. 5. 3 | Tsai J, Yanos P, Roe D (2007): Associations of multiple
197 II, 5. 5. 3 | Pitschel-Walz G, Bäuml J (2007): Psychotherapie bei Schizophrenien –
198 II, 5. 5. 3 | 34(1):S28-S32.~Priebe S (2007): Social outcomes in schizophrenia.
199 II, 5. 5. 3 | Phillips MR, Rahman A (2007): No health without mental
200 II, 5. 5. 3 | S, Chant D, McGrrath J (2007): A systematic review of
201 II, 5. 5. 3 | 10):1123-31.~Sartorius N (2007): Stigma and mental health.
202 II, 5. 5. 3 | Section B, p. 257-333, 2007.~htt df~Vauth R (2006):
203 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
204 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organisation (
205 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
206 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
207 II, 5. 5. 3 | last accessed Dec 13, 2007.~World Health Organization (
208 II, 5. 5. 3 | last accessed Dec 14, 2007.~Wrigley S, Jackson H, Judd
209 II, 5. 5. 3 | disability (Sanchéz-Valle et al, 2007).~ ~ ~ ~
210 II, 5. 5. 3 | partners, (Knapp et al, 2007). The findings reveal that
211 II, 5. 5. 3 | Knapp M, Romeo R, Beecham J (2007): The economic consequences
212 II, 5. 5. 3 | Sánchez-Valle E et al (2007): Estimating the Burden
213 II, 5. 5. 3 | population (Smeets et al, 2007). However, most studies
214 II, 5. 5. 3 | unemployment (Smeets et al, 2007). Psychosocial factors also
215 II, 5. 5. 3 | virtually unknown (Smeets et al, 2007).~ ~Epilepsy and driving~
216 II, 5. 5. 3 | Vanhoutvin JPG, et al (2007): Epilepsy and employment:
217 II, 5. 5. 3 | Myhr et al, 2006; www ). In 2007, a biobank unit for collection
218 II, 5. 5. 3 | centers (Flachenecker et al, 2007).~ ~ ~
219 II, 5. 5. 3 | 100 000 (Vukusic et al, 2007), and a northeast-to-southwest
220 II, 5. 5. 3 | studies (Vukusic et al, 2007). Further studies showed
221 II, 5. 5. 3 | countries (Sobocki et al, 2007). Costs, retrospectively
222 II, 5. 5. 3 | analysis (Sobocki et al, 2007) revealed the positive psychological
223 II, 5. 5. 3 | updated and edited version 2007 (MSTCG, 2007) of the original
224 II, 5. 5. 3 | edited version 2007 (MSTCG, 2007) of the original report
225 II, 5. 5. 3 | conference hosted by EMSP in May 2007, it was conveyed that developments
226 II, 5. 5. 3 | Zettl UK, Elias WG, et al (2007): MS Register in Germany –
227 II, 5. 5. 3 | Czech Republic October 2007.~Forbes RB, Wilson SV, Swingler
228 II, 5. 5. 3 | therapy consensus group) (2007): “Escalating Immunomodulatory
229 II, 5. 5. 3 | Paper , Revised version 2007~Murray CJL, Lopez AD (2000):
230 II, 5. 5. 3 | Pugliatti M, Lauer L, Kobelt G (2007): Estimation of the cost
231 II, 5. 5. 3 | Gosselin S, Confavreux C (2007): Regional variations in
232 II, 5. 5. 3 | Nath et al, 2005; Orphanet, 2007; Vanacore, 2005).~Although,
233 II, 5. 5. 3 | Bundesamt für Statistik, 2007; EUROSTAT, 2002). Several
234 II, 5. 5. 3 | al, 2005; McCrone et al, 2007; Spottke et al, 2005). Direct
235 II, 5. 5. 3 | Schöffski and v.d. Schulenburg, 2007).~ ~PD, employment and indirect
236 II, 5. 5. 3 | disorders is low (Gasser, 2007). Environmental causes have
237 II, 5. 5. 3 | disease (Elbaz and Tranchant, 2007; Quik, 2004; Chade et al
238 II, 5. 5. 3 | 3 million (Dorsey et al, 2007). The burden of PD will
239 II, 5. 5. 3 | Bundesamt für Statistik (2007): ht /.~Bundesministerium
240 II, 5. 5. 3 | Siderowf A, Tanner CM (2007): Projected number of people
241 II, 5. 5. 3 | 128.~Elbaz A, Tranchant C (2007): Epidemiologic studies
242 II, 5. 5. 3 | 10):1139-1145.~Gasser T (2007): Update on the genetics
243 II, 5. 5. 3 | P, Allcock LM, Burn DJ (2007): Predicting the cost of
244 II, 5. 5. 3 | Disord 10(1):19-21.~Orphanet (2007): Prävalenzen seltener Krankheiten:
245 II, 5. 5. 3 | v.d. Schulenburg J-M., 2007. Gesundheitsökonomische
246 II, 5. 6. 1 | Special Report No 272e, 2007). They are a major burden
247 II, 5. 6. 3 | Special Report No 272e, 2007). A survey in Norway found
248 II, 5. 6. 3 | Special Report No 272e, 2007).~ ~The prevalence of physical
249 II, 5. 6. 3 | the knee and hip (Woolf, 2007). One study showed obesity
250 II, 5. 6. 3 | antibodies marker (Combe et al, 2007).~ ~Natural history~ ~Inflammatory
251 II, 5. 6. 3 | manifestations (Naz and Symmons, 2007). Co-morbidity, especially
252 II, 5. 6. 4 | Eurobarometer Special Report No 283, 2007).~ ~The associated health
253 II, 5. 6. 6 | Silman A, Smolen J, Yazici H (2007): EULAR Recommendations
254 II, 5. 6. 6 | European Commission (2007): Health in the European
255 II, 5. 6. 6 | 28~Naz SM and Symmons DP (2007): Mortality in Established
256 II, 5. 6. 6 | Rheum Dis 59:81-82~Woolf AD (2007): What healthcare services
257 II, 5. 7. 1 | 2006; Van Biesen et al, 2007); these studies indicate
258 II, 5. 7. 1 | population (Pontoriero et al, 2007). Renal transplantation
259 II, 5. 7. 2 | Barcelona, 21st - 24th June 2007) (Zoccali and DeJong, 2007)
260 II, 5. 7. 2 | 2007) (Zoccali and DeJong, 2007) and unpublished information
261 II, 5. 7. 3 | Renal Data System, USRDS, 2007) are 1.5-3 times as high
262 II, 5. 7. 3 | patients (Jager and van Dijk 2007) resulted in a concomitant
263 II, 5. 7. 3 | limited (Warady and Chadha, 2007; Ardissino et al 2003).
264 II, 5. 7. 3 | Garcia-Lopez and Epirce, 2007) is shown in Figure 5.7.
265 II, 5. 7. 3 | databases (Stevens et al, 2007). Stage 3-5 CKD prevalence
266 II, 5. 7. 3 | Belgium (Van Biesen et al, 2007) , England (Stevens et al,
267 II, 5. 7. 3 | England (Stevens et al, 2007), Iceland (Viktorsdottir
268 II, 5. 7. 3 | Renal Data System, USRDS ,2007).~ ~Table 5.7.6A. Prevalence
269 II, 5. 7. 3 | 2006; Zoccali and DeJong, 2007), while the prevalence of
270 II, 5. 7. 3 | with decreasing GFR (USRDS 2007 ). Mortality in ESRD patients
271 II, 5. 7. 3 | 2003; Warady and Chadha, 2007; ERA-EDTA Registry, 2005).
272 II, 5. 7. 3 | survival (van Dijk et al, 2007). International studies
273 II, 5. 7. 3 | patients (Jager and van Dijk 2007) resulted in a concomitant
274 II, 5. 7. 4 | diabetes (Loucks et al, 2007; Seligman et al, 2007) in
275 II, 5. 7. 4 | al, 2007; Seligman et al, 2007) in adults and obesity in
276 II, 5. 7. 4 | population) (Jager and van Dijk, 2007). Another factor that must
277 II, 5. 7. 5 | two years.~· In Poland in 2007 a programme to detect CKD
278 II, 5. 7. 5 | mellitus.~· Since April 2007 German dialysis centres,
279 II, 5. 7. 5 | progress.~· In Italy, in March 2007, a report by the Istituto
280 II, 5. 7. 5 | diseases. On September 26th 2007, after a special convention
281 II, 5. 7. 5 | the year up to to March 2007,the first in which this
282 II, 5. 7. 5 | NephroQUEST (Jager and Zoccali, 2007) is an initiative promoted
283 II, 5. 7. 6 | initiative (Jager and Zoccali, 2007). This initiative includes
284 II, 5. 7. 7 | Amsterdam, The Netherlands, June 2007.~Esbjorner E, Berg U, Hansson
285 II, 5. 7. 7 | Renal Cronica en Espana (2007): XLIV ERA-EDTA pre-songress
286 II, 5. 7. 7 | meeting, Barcelona 21st June 2007.~Go AS, Chertow GM, Fan
287 II, 5. 7. 7 | Jager KJ, van Dijk PC (2007): Has the rise in the incidence
288 II, 5. 7. 7 | Nephrol Dial Transplant 2007;22:678-80.~Jager KJ, Zoccali
289 II, 5. 7. 7 | 80.~Jager KJ, Zoccali C (2007): Clinical databases and
290 II, 5. 7. 7 | initiative. Blood Purif 2007;25(3):219-20.~Kimmel PL,
291 II, 5. 7. 7 | Thurston RC, Kawachi I (2007): Socioeconomic disparities
292 II, 5. 7. 7 | NHANES III. Ann Epidemiol 2007 Jan;17(1):19-26.~Lysaght
293 II, 5. 7. 7 | Vecchio LD, Locatelli F (2007): International Study of
294 II, 5. 7. 7 | Health Care Finance Econ 2007 Jul 20.~Rodgers A, Ezzati
295 II, 5. 7. 7 | E, Kanaya AM, Kushel MB (2007): Food insecurity is associated
296 II, 5. 7. 7 | 1999-2002. J Gen Intern Med 2007 Jul;22(7):1018-23.~Smith
297 II, 5. 7. 7 | Klebe B, Middleton R, et al (2007): Chronic kidney disease
298 II, 5. 7. 7 | project results. Kidney Int 2007 Jul;72(1):92-9.~Stewart
299 II, 5. 8. 1 | years (Mannino and Buist, 2007). Moreover, significant
300 II, 5. 8. 3 | Boutin-Forzano et al, 2007).~ ~The IBERPOC study, carried
301 II, 5. 8. 3 | for women (Buist et al, 2007). In Salzburg (Austria),
302 II, 5. 8. 3 | participants (Schirnhofer et al, 2007).~ ~The Obstructive Lung
303 II, 5. 8. 3 | study, Gudmundsson et al (2007) performed an analysis of
304 II, 5. 8. 3 | by Boutin-Forzano et al (2007), different co-morbidities
305 II, 5. 8. 3 | osteopenia (Jorgensen et al, 2007). This increased prevalence
306 II, 5. 8. 3 | Recently, Fabbri and Rabe (2007) proposed the additional
307 II, 5. 8. 3 | treatment of COPD (Bilde et al, 2007). The net cost for COPD
308 II, 5. 8. 3 | than for asthma (Vrbica, 2007)..~ ~
309 II, 5. 8. 4 | of intervention (Mannino 2007).~ ~
310 II, 5. 8. 5 | awareness (Bousquet et al, 2007).~ ~Another important initiative
311 II, 5. 8. 5 | diseases (MacNee et al, 2007).~ ~
312 II, 5. 8. 7 | Baekke Borgeskov H, Lange P (2007): The cost of treating patients
313 II, 5. 8. 7 | non-COPD controls. Respir Med 2007; 101: 539-546.~ ~B N (2007):
314 II, 5. 8. 7 | 2007; 101: 539-546.~ ~B N (2007): Global Alliance against
315 II, 5. 8. 7 | Respiratory Diseases.~Eur Respir J 2007; 29: 233-239.~ ~Boutin-Forzano
316 II, 5. 8. 7 | Charpin D, Annesi-Maesano I. (2007) : Reported prevalence and
317 II, 5. 8. 7 | estimation. Int J Tuberc Lung Dis 2007; 11: 695-702.~ ~Buist AS,
318 II, 5. 8. 7 | pagine)~ ~Fabbri LM, Rabe KF (2007): From COPD to chronic systemic
319 II, 5. 8. 7 | inflammatory syndrome?. Lancet 2007; 370: 797-799.~ ~Fabbri
320 II, 5. 8. 7 | publication, accessed on 16 April 2007)~ ~Gorecka D, Bednarek M,
321 II, 5. 8. 7 | Aine T, Bakke P, Janson C (2007): Mortality in COPD patients
322 II, 5. 8. 7 | Petersen LJ, Backer V (2007): The prevalence of osteoporosis
323 II, 5. 8. 7 | sectional study. Respir Med 2007; 101: 177-185.~ ~Kriegsman
324 II, 5. 8. 7 | MacNee W, Viegi G, Kamel N (2007): New opportunities for
325 II, 5. 8. 7 | Europe: FP7. Eur Respir J 2007; 29: 223-225.~ ~Mannino
326 II, 5. 8. 7 | Mannino DM, Buist AS (2007): Global burden of COPD:
327 II, 5. 8. 7 | M, Jensen RL, Buist AS (2007): COPD prevalence in Salzburg,
328 II, 5. 8. 7 | Disease (BOLD) Study. Chest 2007; 131: 29-36.~ ~Siafakas
329 II, 5. 8. 7 | 126; 1093-1101.~ ~V . (2007): Definition, epidemiology
330 II, 5. 8. 7 | history of COPD. Eur Respir J 2007; 30: 993–1013~ ~Vrbica Ž (
331 II, 5. 8. 7 | 30: 993–1013~ ~Vrbica Ž (2007): COPD and Asthma: comparison
332 II, 5. 9. FB | under debate (Plumb et al, 2007; Story, 2007)~There are
333 II, 5. 9. FB | Plumb et al, 2007; Story, 2007)~There are contrasting data
334 II, 5. 9. FB | ys of age (Bener et al, 2007). On the contrary, the Avon
335 II, 5. 9. FB | J, Brawer R, Brisbon N (2007): The interplay of obesity
336 II, 5. 9. FB | allergy and asthma reports 2007, 7:385-389.~ ~Story RE (
337 II, 5. 9. FB | 7:385-389.~ ~Story RE (2007): Asthma and obesity in
338 II, 5. 9. 1 | asthma alone (Braido et al, 2007). Therefore, an optimal
339 II, 5. 9. 2 | survey (Compalati et al, 2007) has analyzed the results
340 II, 5. 9. 2 | ISAAC) (Björkstén et al, 2007) and the second one was
341 II, 5. 9. 3 | survey by Compalati et al, 2007 reported that the highest
342 II, 5. 9. 3 | The AllergyNet of the May 2007 issue of Allergy (Mantovani
343 II, 5. 9. 3 | Allergy (Mantovani et al, 2007), reported that in 2003
344 II, 5. 9. 3 | was 750.18 Euro (Vrbica, 2007). It was found that all
345 II, 5. 9. 4 | implicated (Osman et al, 2007).~ These findings have been
346 II, 5. 9. 4 | prevalence by only 1% ( Bousquet, 2007) The same study showed a
347 II, 5. 9. 4 | most prevalent (Bousquet, 2007)~ ~Prevalence of both atopic
348 II, 5. 9. 4 | North of Italy (Duse et al, 2007). A modified version of
349 II, 5. 9. 4 | Adolescents (KiGGS) (Sc ud et al, 2007), for instance, information
350 II, 5. 9. 4 | study, (Migliore et al, 2007) performed in 12 I Italian
351 II, 5. 9. 7 | Apr;9(4):636-42~ ~Bj P (2007): Worldwide time trends
352 II, 5. 9. 7 | Pediatr Allergy Immunol. 2007 Jul 25; [Epub ahead of print]~ ~B I (
353 II, 5. 9. 7 | Baiardini I, Brandi S (2007): Allergic rhinitis and
354 II, 5. 9. 7 | Henley K, Canonica GW (2007): Allergy prevalence survey
355 II, 5. 9. 7 | 110(2):228-35~ ~Duse M (2007): High prevalence of atopy,
356 II, 5. 9. 7 | Pediatr Allergy Immunol. 2007 May;18(3):201-8~ ~Erwin
357 II, 5. 9. 7 | Canonica GW, Passalacqua G (2007): Allergic rhinitis in the
358 II, 5. 9. 7 | 5):569-71)~ ~Migliore E (2007): Prevalence of respiratory
359 II, 5. 9. 7 | SIDRIA-2 study. Allergy 2007; 62:293-300~ ~Osman M (2007):
360 II, 5. 9. 7 | 2007; 62:293-300~ ~Osman M (2007): Changing trends in sex
361 II, 5. 9. 7 | Press, 1990: 11-23~ ~Sc W (2007): Allergic diseases. Results
362 II, 5. 9. 7 | study. An Pediatr (Barc). 2007 Feb;66(2):154-8~ ~The UCB
363 II, 5. 9. 7 | 2006;61:407-413~ ~Vrbica Ž (2007): COPD and Asthma: comparison
364 II, 5. 9. 7 | Journal of Public Health 2007; 3(10) - www.hcjz.hr~ ~Wang
365 II, 5. 10. 1 | quality of life (Mills et al, 2007). On the one hand, adequate
366 II, 5. 10. 2 | diagnosis of FA (Rona et al, 2007). For the purpose of this
367 II, 5. 10. 3 | was about 12% (Rona et al, 2007).~ ~Figure 5.10.2. Reported
368 II, 5. 10. 5 | products thereof~Directive 2007/68/EC~Exempted from labelling:~ ~(
369 II, 5. 10. 5 | granted until 25 November 2007. Requests for exemptions
370 II, 5. 10. 5 | recently adopted Directive 2007/68/EC (EC, 2007) establishing
371 II, 5. 10. 5 | Directive 2007/68/EC (EC, 2007) establishing a list of
372 II, 5. 10. 6 | urgently needed (Asero et al, 2007).~ ~Furthermore, any efforts
373 II, 5. 10. 6 | individuals (de Blok et al, 2007), but it takes as well a
374 II, 5. 10. 6 | Taylor, 2006; Thomas et al, 2007).~ ~
375 II, 5. 10. 7 | Clare Mills EN, Vieths S (2007): IgE-Mediated food allergy
376 II, 5. 10. 7 | L, Mills C, AEJ Dubois (2007): A framework for measuring
377 II, 5. 10. 7 | European Commission (2007): Commission Directive 2007/
378 II, 5. 10. 7 | 2007): Commission Directive 2007/68/EC of 27 November 2007
379 II, 5. 10. 7 | 2007/68/EC of 27 November 2007 amending Annex IIIa to Directive
380 II, 5. 10. 7 | European Union L 310, 28.11.2007, pp. 11–14.~ ~European Food
381 II, 5. 10. 7 | Crevel RWR, van Ree R (2007): The prevalence, cost and
382 II, 5. 10. 7 | Goldhahn K, Dahlstrom J (2007): The prevalence of food
383 II, 5. 10. 7 | C, Privalle L, Vieths S (2007): Evaluating the effect
384 II, 5. 10. 7 | report. Food Chem Toxicol. 2007 Jul;45(7):1116-22. Epub
385 II, 5. 10. 7 | Jul;45(7):1116-22. Epub 2007 Jan 9.~ ~Woods RK, Abramson
386 II, 5. 11. 3 | standards (B Bocca et al, 2007). Similarly, in Finland,
387 II, 5. 11. 3 | of the Total Environment, 2007;388:24-34.~L Dotterud, E
388 II, 5. 11. 3 | Gudjonsson and Elder, 2007).~ ~Acne~Acne is so common
389 II, 5. 11. 7 | Gudjonsson JE, Elder JT (2007): Psoriasis: epidemiology.
390 II, 5. 11. 7 | epidemiology. Clin Dermatol 2007;25:535-546.~ ~Hay R (2005):
391 II, 5. 11. 7 | clinical excellence (NICE) (2007): clinical guideline 57 –
392 II, 5. 11. 7 | eczema in children, London: 2007.~ ~Nielsen NH, Mennè T (
393 II, 5. 12. 1 | al, 2000; Bosetti et al, 2007). The patterns in mortality
394 II, 5. 12. 2 | countries as to January 2007. For Belgium, data were
395 II, 5. 12. 7 | Negri E, La Vecchia C (2007): Worldwide mortality from
396 II, 5. 14. 1 | lifetime (Selwitz and Ismail, 2007). To avoid pain and discomfort,
397 II, 5. 14. 6 | which took place in May 2007, Member States of the World
398 II, 5. 14. 6 | plan for oral health (WHO, 2007). The adoption of this action
399 II, 5. 14. 8 | RH, Ismail AI, Pitts NB (2007): Dental caries. Lancet
400 II, 5. 14. 8 | Dental caries. Lancet 2007; 369: 51–59.~Wid A (2004):
401 II, 5. 14. 8 | Health Organization (WHO) (2007): Resolution WHA60.17 “Oral
402 II, 5. 15. 2 | published articles (McKusick, 2007). OMIM lists 5,760 genetic
403 II, 5. 15. 2 | Disorders (NORD database, 2007). The number of RD for which
404 II, 5. 15. 3 | in 2001 (Drummond et al, 2007) on request by the French
405 II, 5. 15. 3 | therapies (Drummond et al, 2007; Dear et al, 2006; Kesselman
406 II, 5. 15. 4 | years.~ ~Regulation 1394/2007 of the European Parliament
407 II, 5. 15. 4 | products (European Commission, 2007), amending Directive 2001/
408 II, 5. 15. 4 | first reading) on 31st May 2007, is also directly linked
409 II, 5. 15. 6 | Kanavos P, Ubel P, Rovira J (2007): Assessing the economic
410 II, 5. 15. 6 | Technol Assess Health Care. 2007 Winter;23(1):36-42~European
411 II, 5. 15. 6 | at: htt , (accessed 12.05.2007).~ ~European Commission (
412 II, 5. 15. 6 | European Commission (2007): Regulation (EC) No 1394/
413 II, 5. 15. 6 | Regulation (EC) No 1394/2007 of the European Parliament
414 II, 5. 15. 6 | the Council of 13 November 2007 on advanced therapy medicinal
415 II, 5. 15. 6 | At:~htt m (accessed 12.05.2007)~Eurordis (2005): Rare diseases:
416 II, 5. 15. 6 | at:~htt 8 (accessed 12.05.2007)~Haffner ME (2006): Adopting
417 II, 5. 15. 6 | 7523):1016-9.~McKusick VA (2007): Mendelian Inheritance
418 II, 5. 15. 6 | Hum Genet, 80: 588-604, 2007~NORD database of rare diseases.
419 II, 5. 15. 6 | at: htt l (accessed 08.05.2007)~Orphanet database of rare diseases
420 II, 5. 15. 6 | at: htt m (accessed 15.05.2007)~Wastfelt M, Fadeel B, Henter
421 II, 6. 3. 3 | per million.~Source: ECDC, 2007~ ~ ~ ~ ~The epidemic in
422 II, 6. 3. 4 | With the EU expansion in 2007, Romania will be the country
423 II, 6. 4. 2 | the EWRS. Starting from 2007, the Centre has also been
424 II, 7. 1 | leading cause of death (KfV, 2007). There are large differences
425 II, 7. 1 | WHO European Region. In 2007, the European Council released
426 II, 7. 3 | summary 2003 – 2005” (see KfV, 2007)1. See also the executive
427 II, 7. 3. 3 | of injuries (Bauer et al, 2007).~ ~
428 II, 7. 4 | Council Recommendation of 2007 calls upon Member States
429 II, 7. 4. 1 | safety (MacKay & Vincenten, 2007); it has also issued a “
430 II, 7. 4. 1 | Accidents and Injury Prevention, 2007).~ ~Link to the project:~www ~ ~
431 II, 7. 5 | injuries and violence” (WHO, 2007; Racioppi et al, 2004).
432 II, 7. 5 | promotion of safety” on May 31, 2007 (Council of the European
433 II, 7. 5 | Council of the European Union, 2007).~ ~According to this Recommendation,
434 II, 7. 5 | the European Union” (KfV, 2007).~ ~Also policy tools regarding “
435 II, 7. 7 | R, Nossek G, Steiner M (2007): Freizeitunfallstatistik
436 II, 7. 7 | Council of the European Union (2007): Council Recommendation
437 II, 7. 7 | Journal of the European Union 2007/C164/1 of July 18, 2007 (
438 II, 7. 7 | 2007/C164/1 of July 18, 2007 (CELEX-Nr. 32007H0718).~ ~
439 II, 7. 7 | Verkehrssicherheit (KfV) (2007): Injuries in the European
440 II, 7. 7 | MacKay M and Vincenten J (2007): Child Safety Summary Report
441 II, 7. 7 | Health Organization (WHO) (2007): Preventing injuries and
442 II, 8. 1. 1 | context (Schalock et al, 2007). Within this framework,
443 II, 8. 1. 2 | comprehensive report (APPLICA et al, 2007). Where they cover the same
444 II, 8. 1. 4 | module has been held in 2007 in Dublin at a European
445 II, 8. 1. 5 | of the Action Plan (2006-2007)6 focused on the active
446 II, 8. 1. 6 | CESEP & ALPHAMETRICS (2007): Men and women with disabilities
447 II, 8. 2. 1 | countries of the world (WHO, 2007).~People with intellectual
448 II, 8. 2. 1 | Schrojenstein Lantman-de Valk et al 2007).~Further, people with intellectual
449 II, 8. 2. 1 | the European Union. In May 2007, an examination of a sample
450 II, 8. 2. 1 | Interim Reports for 2006 and 2007 that can be found on the
451 II, 8. 2. 1 | approach (Schalock et al., 2007), emphasizing deficits in
452 II, 8. 2. 1 | interaction (Schalock et al., 2007).~ ~
453 II, 8. 2. 1 | Schrojenstein Lantman-de Valk et al (2007) presented evidence that
454 II, 8. 2. 1 | Project: Submitted 30 June 2007).~
455 II, 8. 2. 1 | Walsh, P.N., et al., (2007). POMONA Interim Report. htt df
456 II, 8. 2. 1 | M.L. and Yeager, M.H. (2007). The Renaming of Mental
457 II, 8. 2. 1 | Schellevis, G.J. Dinant (2007). Health problems of people
458 II, 8. 2. 1 | Linehan C, Kerr MP, Walsh PN (2007): Developing health indicators
459 II, 8. 2. 1 | World Health Organisation (2007). Atlas - Global Resources
460 II, 8. 2. 2 | in a Report published in 2007 (APPLICA et al, 2007).~ ~
461 II, 8. 2. 2 | in 2007 (APPLICA et al, 2007).~ ~Definitions~ ~Visual
462 II, 8. 2. 2 | implementation of VISION 2020 (WHO, 2007).~The three core approaches
463 II, 8. 2. 2 | Living Conditions (EU-SILC) (2007): Men and women with disabilities
464 II, 8. 2. 2 | Document WHO/PBL/03.91~WHO (2007): Global initiative for
465 II, 8. 2. 3 | in a Report published in 2007 (APPLICA et al, 2007).~ ~
466 II, 8. 2. 3 | in 2007 (APPLICA et al, 2007).~ ~Definitions~ ~There
467 II, 8. 2. 3 | Living Conditions (EU-SILC) (2007): Men and women with disabilities
468 II, 9 | with a higher risk (Waller, 2007; EUROCAT, 2004). In the
469 II, 9 | European Healthy Ageing, 2007).~ ~Smoking. The acceleration
470 II, 9 | European Healthy Ageing, 2007).~ ~Lack of physical activity.
471 II, 9 | European Healthy Ageing, 2007).~ ~Risk factors for falls
472 II, 9. 1. 1 | countries that acceded in 2007 (Bulgaria and Romania).~ ~ ~ ~
473 II, 9. 1. 1 | countries that acceded in 2007, however, was higher at
474 II, 9. 1. 1 | al, 2000a; Marret et al, 2007). The preterm birth rate
475 II, 9. 1. 1 | 1000-1499g (Platt et al, 2007).~ ~Table 9.1.1.6. CP rates
476 II, 9. 1. 1 | maternal age. Hum Reprod 2007;22(5):1264-72.~Luke B, Brown
477 II, 9. 1. 1 | plurality. Fertil Steril 2007;88(2):283-93.~Magee BD (
478 II, 9. 1. 1 | Topp M, Torrioli MG, et al (2007): Trends in cerebral palsy
479 II, 9. 1. 1 | a database study. Lancet 2007;369(9555):43-50.~Prysak
480 II, 9. 1. 1 | Petrou S, Agostino R, et al (2007): Characteristics of neonatal
481 II, 9. 1. 1 | MOSAIC study. Pediatrics 2007;120(4):e815-25.~ ~van Roosmalen
482 II, 9. 1. 1 | Alexander S, Breart G (2007): Variation in rates of
483 II, 9. 1. 1 | reality or artefact? Bjog 2007;114(9):1097-103.~ ~Zeitlin
484 II, 9. 1. 2 | well as the Ukraine since 2007. The only EU countries with
485 II, 9. 1. 2 | on its website (EUROCAT, 2007). Those with a total prevalence
486 II, 9. 1. 2 | hypoplastic left heart (EUROCAT, 2007). TOPFA is not common for
487 II, 9. 1. 2 | for 2000-2004 (EUROCAT, 2007), while rates of 0.6 per
488 II, 9. 1. 2 | in Europe (Loane et al, 2007) and elsewhere in the world.
489 II, 9. 1. 2 | pregnancy (Loane et al, 2007). In Italy however, rates
490 II, 9. 1. 2 | experienced (Loane et al, 2007). The great majority of
491 II, 9. 1. 2 | prenatally diagnosed (EUROCAT, 2007), but TOPFA is rare as the
492 II, 9. 1. 2 | with a higher risk (Waller, 2007; EUROCAT, 2004). In the
493 II, 9. 1. 2 | 2005b; Abramsky et al, 2007; EUROCAT, 2005) and is the
494 II, 9. 1. 2 | and de Jong van den Berg, 2007). Some European countries
495 II, 9. 1. 2 | defects (De Wals et al, 2007). For example, this has
496 II, 9. 1. 2 | is prenatal (Garne et al, 2007). This is a potentially
497 II, 9. 1. 2 | Folic Acid Working Group (2007): "Should Europe Fortify
498 II, 9. 1. 2 | de Jong van den Berg LT (2007): Growing gap in folic acid
499 II, 9. 1. 2 | Netherlands. Community Genetics 2007; 10:93-6.~De Wals P et al, (
500 II, 9. 1. 2 | 93-6.~De Wals P et al, (2007): Reduction in neural tube
|
|
| |
